Analyst Ratings for Kymera Therapeutics (KYMR)
KYMR Rating Summary
KYMR Price Target Summary
- Highest: $170.00 (Guggenheim)
- Lowest: $80.00 (Citi)
- Average: $128.43
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
=
Avg. $ Target:
$128.43 (+10.1%)
* Over Last 12-Mos
Rating Score: 9 / 10
Percentile Rank: 89%
Rating Score: 9 / 10
Percentile Rank: 89%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 9/10/2026 | Wolfe Research | Andy Chen | Upgrade | Outperform (Peerperform) |
N/A (N/A) |
115.43 (116.60) |
1.01% | Details |
| 8/22/2026 | TD Cowen | Tyler Van Buren | New Coverage | Buy (N/A) |
N/A (N/A) |
121.50 (116.60) |
-4.03% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
